Gene · 7049
Papers2,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The amniotic fluid proteome changes with gestational age in normal pregnancy: a cross-sectional study. | Sci Rep | 2022 | 35022423 | PubTator, text mining | PubMed |
| Rheumatoid Arthritis Synovial Inflammation Quantification Using Computer Vision. | ACR Open Rheumatol | 2022 | 35014221 | PubTator, text mining | PubMed |
| Biological and molecular profile of fracture non-union tissue: A systematic review and an update on current insights. | J Cell Mol Med | 2022 | 34984803 | PubTator, text mining | PubMed |
| Small extracellular vesicles: from mediating cancer cell metastasis to therapeutic value in pancreatic cancer. | Cell Commun Signal | 2022 | 34980146 | PubTator, text mining | PubMed |
| Systems biology of angiogenesis signaling: Computational models and omics. | WIREs Mech Dis | 2022 | 34970866 | PubTator, text mining | PubMed |
| Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance). | Clin Cancer Res | 2022 | 34965953 | PubTator, text mining | PubMed |
| Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem Cells. | Inflamm Bowel Dis | 2022 | 34918082 | PubTator, text mining | PubMed |
| miR-181a Promotes Multiple Protumorigenic Functions by Targeting TGFβR3. | J Invest Dermatol | 2022 | 34890627 | PubTator, text mining | PubMed |
| Dual inhibition of TGF-β and PD-L1: a novel approach to cancer treatment. | Mol Oncol | 2022 | 34854206 | PubTator, text mining | PubMed |
| Schizophrenia is defined by cell-specific neuropathology and multiple neurodevelopmental mechanisms in patient-derived cerebral organoids. | Mol Psychiatry | 2022 | 34789849 | PubTator, text mining | PubMed |
| Expanding the clinicopathological spectrum of TGFBR3-PLAG1 rearranged salivary gland neoplasms with myoepithelial differentiation including evidence of high-grade transformation. | Genes Chromosomes Cancer | 2022 | 34755406 | PubTator, text mining | PubMed |
| Exploiting Canonical TGFβ Signaling in Cancer Treatment. | Mol Cancer Ther | 2022 | 34670783 | PubTator, text mining | PubMed |
| MicroRNAs and their role in the malignant transformation of oral leukoplakia: a scoping review. | Med Oral Patol Oral Cir Bucal | 2022 | 34564679 | PubTator, text mining | PubMed |
| Genome-wide association study reveals susceptibility loci for self-reported headache in a large community-based Asian population. | Cephalalgia | 2022 | 34404248 | PubTator, text mining | PubMed |
| Rapidly fatal SMARCA4-deficient undifferentiated sarcoma originating from hybrid hemosiderotic fibrolipomatous tumor/pleomorphic hyalinizing angiectatic tumor of the foot. | Virchows Arch | 2022 | 34389899 | PubTator, text mining | PubMed |
| Identification of Missense Extracellular Matrix Gene Variants in a Large Glaucoma Pedigree and Investigation of the N700S Thrombospondin-1 Variant in Normal and Glaucomatous Trabecular Meshwork Cells. | Curr Eye Res | 2022 | 34143713 | PubTator, text mining | PubMed |
| Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer. | Gut | 2022 | 34059508 | PubTator, text mining | PubMed |
| Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance). | Angiogenesis | 2022 | 34028627 | PubTator, text mining | PubMed |
| A simultaneous next-generation sequencing approach to the diagnosis of couple infertility. | Minerva Endocrinol (Torino) | 2022 | 33988008 | PubTator, text mining | PubMed |
| Rhabdomyosarcoma and pleomorphic sarcoma in the same location : Recurrence or new entity? | Wien Klin Wochenschr | 2022 | 33905030 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7049/papers?page=35